| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/13/2001 | US6200981 For treating inflammatory diseases such as asthma, inflammatory bowel disease, psoriasis, rheumatoid arthritis, myocardial ischaemia, cystic fibrosis, arthereosclerosis, restenosis, peridontal disease, septic shock, osteoarthritis |
| 03/13/2001 | US6200980 Method of treating a patient having precancerous lesions with phenyl purinone derivatives |
| 03/13/2001 | US6200979 Administering substituted pyrazoles and pyzazolopyrimidines for treating phobias obsessive-compulsive disorder, post-traumatic stress disorder, single episode depression, recurrent depression, dysthymia, bipolar disorders |
| 03/13/2001 | US6200978 For preventing or treating inflammatory diseases such as arthritis, psoriasis, asthma, or inflammatory bowel disease, disorders of respiratory function, gastrointestinal disorders such as functional bowel disease, as analgesics |
| 03/13/2001 | US6200977 Pyrimidine derivatives |
| 03/13/2001 | US6200975 For cognition enhancement therapy |
| 03/13/2001 | US6200974 For producing an anti-fibroproliferative effect |
| 03/13/2001 | US6200972 Heterocyclic esters and amides |
| 03/13/2001 | US6200971 For treating atherosclerosis |
| 03/13/2001 | US6200970 For treating a disease associated with overstimulation of an ampa receptor, or hyperactivity of an excitatory amino acid |
| 03/13/2001 | US6200969 Contacting cells with reagent which suppresses protease activity of interleukin-1.beta.-converting enzyme (ice)/ced-3 family, inhibiting apoptosis in cell population to expanding or increasing survival of cell population |
| 03/13/2001 | US6200968 Particle-forming compositions containing fused pyrrolocarbazoles |
| 03/13/2001 | US6200966 For treating chronic and acute inflammation of airways, including asthmatic conditions |
| 03/13/2001 | US6200965 Use of same to reduce plasma levels of testosterone and/or dyhydrotestosterone to treat prostate cancer and benign prostatic hypertrophy |
| 03/13/2001 | US6200964 Silicone gel containing salicylic acid |
| 03/13/2001 | US6200963 Useful as female and male contraceptive agents |
| 03/13/2001 | US6200962 As antioxidants for therapy and prophylaxis oxidative damage which is believed to be involved in development of human disorders i.e., atherosclerosis, cancer, rheumatoid artritis |
| 03/13/2001 | US6200960 Inhibition of proliferation of cells |
| 03/13/2001 | US6200958 Agent for treating high-risk impaired glucose tolerance |
| 03/13/2001 | US6200957 Useful for treatment of variety of sex-hormone related and other conditions in both men and women |
| 03/13/2001 | US6200956 Nucleic acid-containing composition, preparation and use thereof |
| 03/13/2001 | US6200955 Heparin binding peptides |
| 03/13/2001 | US6200950 Nutritional suppliment |
| 03/13/2001 | US6200807 Antisense inhibition of SHP-2 expression |
| 03/13/2001 | US6200801 A polycation and a binding moiety of defined amino acid sequence capable of binding to a serpin enzyme complex receptor for targeted gene delivery; gene therapy; antisense agents |
| 03/13/2001 | US6200787 Phenylalanyl tRNA synthetase polypeptides from streptococcus pneumoniae |
| 03/13/2001 | US6200777 Human p101 polynucleotides |
| 03/13/2001 | US6200775 Nucleotide sequence coding a polypeptide associated with the diagnosis and treatment of infections |
| 03/13/2001 | US6200771 Determination cyclooxygenase inhibition and phosphodiesteraseinhibition; calibration |
| 03/13/2001 | US6200758 Detecting a psychological disorders; obtain biopsies, detect nucleotide sequence variation, presence of variation indicates psychological disorders |
| 03/13/2001 | US6200624 Controlling concentration of proteins, carbohydrates and fats; infants |
| 03/13/2001 | US6200606 Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration |
| 03/13/2001 | US6200605 Adminisering a composition of a polysaccharide and a preservative by means of a dietary supplement |
| 03/13/2001 | US6200604 Sublingual buccal effervescent |
| 03/13/2001 | US6200599 Ortho ester lipids |
| 03/13/2001 | US6200598 Active materials entrapped within liposome interior |
| 03/13/2001 | US6200597 Unit dosage form containing retinoid |
| 03/13/2001 | US6200593 Contraceptive method employing buccal delivery of steroidal active agents |
| 03/13/2001 | US6200592 Immine response modifier compounds for treatment of TH2 mediated and related diseases |
| 03/13/2001 | US6200587 Wound healing agents |
| 03/13/2001 | US6200574 Chemical composition for aiding the absorption, binding and elimination of undigested fat |
| 03/13/2001 | US6200573 Provides relief from both dynamic and mechanical obstructive effects of benign prostatic hyperplasia. |
| 03/13/2001 | US6200568 Composition and method of treating cancer with tannic acid and tannin complexes |
| 03/13/2001 | US6200567 An antibody that binds to the common beta c chain of the receptor for gm-csf, il-3 and il-5 |
| 03/13/2001 | US6200566 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy |
| 03/13/2001 | US6200558 Peptide, polypeptide, protein, oligonucleotide or nucleic acid, to which is bound a nitric oxide-releasing n2o2-functional group |
| 03/13/2001 | US6200551 Treatment for dry mouth employing carbamide peroxide |
| 03/13/2001 | US6200549 Contains less than 0.0001% w/w surfactant based upon the weight of medicament |
| 03/13/2001 | US6200547 Carrier including particles that include iron and carbon; therapeutic amount of doxorubicin or paclitaxel adsorbed on the particles. |
| 03/13/2001 | US6199607 Formulation for inhalation |
| 03/13/2001 | CA2170647C Multiple unit tableted dosage form i |
| 03/13/2001 | CA2167651C Biologically highly active bicyclic aromatic compositions; pharmaceutical and cosmetic compositions containing the same and their use |
| 03/13/2001 | CA2146238C Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| 03/13/2001 | CA2033937C Hemihydrate |
| 03/13/2001 | CA2010934C Sustained release bolus effective for the prolonged prevention, treatment or control of nematode, acarid and endo- and ectoparasitic infestations of ruminants |
| 03/11/2001 | CA2486805A1 A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate |
| 03/10/2001 | CA2282185A1 Oenothein medicaments |
| 03/08/2001 | WO2001017211A2 Communications system |
| 03/08/2001 | WO2001016377A2 Diagnostics and therapeutics for osteoporosis |
| 03/08/2001 | WO2001016365A1 Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids |
| 03/08/2001 | WO2001016347A1 The hematopoietic, myeloprotecting, antitumor immune cells generating and radiosensitizing polysaccharide isolated from panax ginseng |
| 03/08/2001 | WO2001016345A2 Sequence-specific dna recombination in eukaryotic cells |
| 03/08/2001 | WO2001016343A1 Antibody dependent enhancement (ade) of alphavirus infection |
| 03/08/2001 | WO2001016331A1 Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression |
| 03/08/2001 | WO2001016322A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | WO2001016312A2 Nucleic acid based modulators of gene expression |
| 03/08/2001 | WO2001016306A2 Chimeric antisense oligonucleotides and cell transfecting formulations thereof |
| 03/08/2001 | WO2001016297A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | WO2001016288A2 Dna encoding the human serine protease c-e |
| 03/08/2001 | WO2001016278A1 Color safe laundry methods employing zwitterionic formulation components |
| 03/08/2001 | WO2001016218A1 Rapidly decomposing chitosan-based pellets |
| 03/08/2001 | WO2001016171A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 03/08/2001 | WO2001016170A2 Card proteins involved in cell death regulation |
| 03/08/2001 | WO2001016156A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | WO2001016147A1 Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 03/08/2001 | WO2001016145A1 Immunopotentiating compositions |
| 03/08/2001 | WO2001016139A1 Androgen receptor modulator compounds and methods |
| 03/08/2001 | WO2001016138A1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
| 03/08/2001 | WO2001016137A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 03/08/2001 | WO2001016136A2 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/08/2001 | WO2001016135A2 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | WO2001016134A1 Selective antagonists of a2b adenosine receptors |
| 03/08/2001 | WO2001016133A2 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
| 03/08/2001 | WO2001016132A1 4,5-diaryloxazole compounds with prostaglandin 12 (pg12) agonistic activity |
| 03/08/2001 | WO2001016130A1 Substituted indolinones as tyrosine kinase inhibitors |
| 03/08/2001 | WO2001016128A1 Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes |
| 03/08/2001 | WO2001016123A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 03/08/2001 | WO2001016122A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 03/08/2001 | WO2001016121A1 Heterocyclic compounds and methods of use thereof |
| 03/08/2001 | WO2001016120A1 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
| 03/08/2001 | WO2001016114A2 Heterocyclic compounds and methods for modulating cxcr3 function |
| 03/08/2001 | WO2001016108A2 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 03/08/2001 | WO2001016106A1 Benzamide formulation with histone deacetylase inhibitor activity |
| 03/08/2001 | WO2001016103A1 Fused pyrrolecarboxamides: gaba brain receptor ligands |
| 03/08/2001 | WO2001016097A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 03/08/2001 | WO2001016096A2 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
| 03/08/2001 | WO2001016094A1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments |
| 03/08/2001 | WO2001016093A1 SUBSTITUTED α-HYDROXY ACID CASPASE INHIBITORS AND THE USE THEREOF |
| 03/08/2001 | WO2001015777A1 Pulmonary-administration of mineral ascorbates |
| 03/08/2001 | WO2001015755A2 Methods and compositions for delivery of pharmaceutical agents |